大肠杆菌Nissle 1917鞭毛蛋白FliC的结构特性及刺激Caco-2细胞作用的研究

试验旨在分析大肠杆菌Nissle 1917鞭毛蛋白FliC(FliC_(EcN))的结构特征及其对Caco-2细胞的刺激作用。试验通过大肠杆菌BL21(DE3)表达FliCEcN蛋白、经NTA柱纯化FliC_(EcN)蛋白并通过SDS-PAGE和Westernblot验证,利用SOPMA和Alphofold2预测FliC_(EcN)蛋白的结构模型、表面增强拉曼光谱和圆二色谱解析FliC_(EcN)蛋白的结构,使用FliC_(EcN)蛋白刺激Caco-2细胞后,检测免疫相关因子的分泌水平。结果显示,FliC_(EcN)蛋白的大小为64kDa,能够被抗His单克隆抗体特异识别;FliC_(EcN)蛋白的氨基和羧基末端主要由α-螺旋组成,中间结构域主要由β-折叠组成。FliC_(EcN)蛋白酰胺Ⅰ区最大吸收峰均位于1656 cm^(-1)处,主要二级结构为α-螺旋和β-折叠;FliC_(EcN)的α-螺旋占比44.4%,β-折叠占比23.4%,β-转角占比13.5%,无规则卷曲占比19.0%;FliC_(EcN)蛋白能够有效刺激Caco-2细胞分泌白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和白细胞介素-10(IL-10);随着刺激时间延长,IL-6的分泌水平呈下降趋势,IL-10和TNF-α的分泌水平呈增加趋势。研究表明,α-螺旋和β-折叠是构成FliC_(EcN)的主要结构,可促进其构象的正确折叠和维持其三维结构稳定,FliC_(EcN)蛋白刺激Caco-2细胞分泌IL-6、IL-10、TNF-α的水平存在差异。

重组体pET-28a-alkB/E.coli降解页岩油泥石油烃的功能研究

为了降解页岩油泥中的石油烃,构建基因工程菌,表达石油烃降解关键酶以提高油泥的降解效果。以Pseudomonas qingdaonensis基因组为模板扩增alkB基因,连接至载体pET-28a,转化至E.coli BL21(DE3)中,SDS-PAGE和Western-blot鉴定表达的外源蛋白。pET-28a-alkB/E.coli处理原油和页岩油泥,采用气相色谱法评估降解效果。发现alkB基因在大肠杆菌中能表达外源蛋白,且14 d原油及页岩油泥的降解率分别为47.5%和47.1%,表明重组体pET-28a-alkB/E.coli具备降解页岩油泥石油烃的功能。

Exploring the modulatory role of bovine lactoferrin on the microbiome and the immune response in healthy and Shiga toxin‑producing E.coli challenged weaned piglets

Background Post-weaned piglets suffer from F18+Escherichia coli(E.coli)infections resulting in post-weaning diar-rhoea or oedema disease.Frequently used management strategies,including colistin and zinc oxide,have contrib-uted to the emergence and spread of antimicrobial resistance.Novel antimicrobials capable of directly interacting with pathogens and modulating the host immune responses are being investigated.Lactoferrin has shown promising results against porcine enterotoxigenic E.coli strains,both in vitro and in vivo.Results We investigated the influence of bovine lactoferrin(bLF)on the microbiome of healthy and infected weaned piglets.Additionally,we assessed whether bLF influenced the immune responses upon Shiga toxin-producing E.coli(STEC)infection.Therefore,2 in vivo trials were conducted:a microbiome trial and a challenge infection trial,using an F18+STEC strain.BLF did not affect theα-andβ-diversity.However,bLF groups showed a higher relative abundance(RA)for the Actinobacteria phylum and the Bifidobacterium genus in the ileal mucosa.When analysing the immune response upon infection,the STEC group exhibited a significant increase in F18-specific IgG serum levels,whereas this response was absent in the bLF group.Conclusion Taken together,the oral administration of bLF did not have a notable impact on theα-andβ-diversity of the gut microbiome in weaned piglets.Nevertheless,it did increase the RA of the Actinobacteria phylum and Bifi-dobacterium genus,which have previously been shown to play an important role in maintaining gut homeostasis.Furthermore,bLF administration during STEC infection resulted in the absence of F18-specific serum IgG responses.

Impact of an oligosaccharide-based polymer on the metabolic profiles and microbial ecology of weanling pigs experimentally infected with a pathogenic E.coli

Background Our previous study has reported that supplementation of oligosaccharide-based polymer enhances gut health and disease resistance of pigs infected with enterotoxigenic E.coli(ETEC)F18 in a manner similar to carbadox.The objective of this study was to investigate the impacts of oligosaccharide-based polymer or antibiotic on the host metabolic profiles and colon microbiota of weaned pigs experimentally infected with ETEC F18.Results Multivariate analysis highlighted the differences in the metabolic profiles of serum and colon digesta which were predominantly found between pigs supplemented with oligosaccharide-based polymer and antibiotic.The relative abundance of metabolic markers of immune responses and nutrient metabolisms,such as amino acids and carbohydrates,were significantly differentiated between the oligosaccharide-based polymer and antibiotic groups(q<0.2 and fold change>2.0).In addition,pigs in antibiotic had a reduced(P<0.05)relative abundance of Lachnospiraceae and Lactobacillaceae,whereas had greater(P<0.05)Clostridiaceae and Streptococcaceae in the colon digesta on d 11 post-inoculation(PI)compared with d 5 PI.Conclusions The impact of oligosaccharide-based polymer on the metabolic and microbial profiles of pigs is not fully understood,and further exploration is needed.However,current research suggest that various mechanisms are involved in the enhanced disease resistance and performance in ETEC-challenged pigs by supplementing this polymer.

Characteristics of β-Lactamase Synthesis in E. coli and K. pneumanie Strains in Nosocomial Infections

Background: Recently micro-organisms that synthesize extended-spectrum β-lactamase (ESBLs) were increased. The peculiarities of ESBL synthesis of Escherichia coli and Klebsiella pneumoniae strains that cause nosocomial urinary tract infections, surgical site infections and pneumonia in surgical clinic were studied. ESBL synthesis were observed 38.9% of E. coli strains obtained from urine, 92.3% of strains obtained from surgical site infections, and 50% of strains obtained from sputum. ESBL synthesis were observed 37.5% of K. pneumoniae strains obtained from urine, 85.7% of strains obtained from surgical site infections, and 60% of strains obtained from sputum. Different levels of ESBL synthesize of E. coli and K. pneumoniae strains isolated from different pattern is discussed. Conclusion. ESBL synthesis is common in E. coli and K. pneumoniae strains, which cause nosocomial infections. The frequency of occurrence of ESBL s synthesis among of these strains depends on clinical forms of nosocomial infections.

The Transport and Persistence of Escherichia coli in Leachate from Poultry Litter Amended Soils

Fecal coliform bacteria such as Escherichia coli (E. coli) are one of the main sources of groundwater pollution. An assessment of the transport and Persistence of E. coli in poultry litter amended Decatur silty Clay soil and Hartsells Sandy soil was conducted using soil columns and simulated groundwater leaching. Enumeration of initial E. coli was determined to range from 2.851 × 103 to 3.044 × 103 CFU per gram of soil. These results have been used in a batch study to determine the persistence rate of E. coli in Decatur silty Clay soil and Hartsells Sandy soil. Results prove that E. coli survival growth rate increases for clay soil later than and at a higher rate than sandy soil. The column study has determined that E. coli was transported at a rate of 3.7 × 106 CFU for Decatur silty loam and 6.3 × 106 CFU for Hartsells sandy per gram of soil. Further, linear regression analysis predictions show higher porosity and soil moisture content affect transport, and Hartsells sandy soil has higher transport of E. coli due to its higher porosity and lower volumetric water content.

Growth Inhibition of Escherichia coli and Staphylococcus epidermidis from Various Types of Honey

Honey has long been considered a wound treatment used to keep cuts and other epidermal injuries clean. This study tested that claim by comparing manuka honey used in medicine today, local unprocessed honey taken straight from a hive, and pasteurized honey found at a store, on strains of E. coli and S. epidermidis. The study evaluated the effects these honeys had on bacterial growth to determine which had the greatest inhibition of bacterial growth. To determine this, plates streaked with strains of E. coli or S. epidermidis bacteria and agar wells filled with one of the honeys were incubated and subsequently the diameter of the zone of inhibition was measured. After 20 trials using each honey and bacteria type, manuka and unprocessed were shown to have a statistically significant advantage over the pasteurized honey at inhibiting the growth of E. coli and S. epidermidis, though it was variable whether manuka had an advantage over the unprocessed honey.

Evaluating the Potential of Nitrofurantoin and Fosfomycin for E.coli UTIs: A Susceptibility Study

This study was designed to find the susceptibility of Nitrofurantoin and Fosfomycin among urinary isolates of Escherichia.coli.Four hundred(400)urine samples were collected for susceptibility of nitrofurantoin and fosfomycin among urinary isolates of E.coli.All indoor and outdoor patients'urinary samples yielded growth of E.coli.Mid-stream urine specimens were inoculated on blood agar and CLED agar and incubated at 35±2°C.Growth was observed,and Escherichia coli was identified by Gram staining,Catalase,Motility test and API 20E(Bio murex)as per standard procedure.Antimicrobial susceptibility testing of isolates for nitrofurantoin and fosfomycin was carried out by the modified Kirby-Bauer disc diffusion method according to CLSI guidelines ATCC 25922.E.coli was used as a quality control strain.A total of 400 samples were tested susceptibility of nitrofurantoin and fosfomycin among urinary isolates of E.coli during this period.A total of 400 samples yielded the growth of E.coli,out of which 178(44.5%)were male and 222(55.5%)were female samples.Among males,18(10%)were tolerant to nitrofurantoin,and 2(1.1%)were tolerant to fosfomycin.Among females,9(4.09%)were susceptible to nitrofurantoin while 6(2.72%)were susceptible to fosfomycin.Among age groups below 45 years old,6(4.76%)were tolerant to nitrofurantoin,and 2(1.58%)were sensitive to fosfomycin.Between 46-66 years old,4(2.81%)were sensitive to nitrofurantoin,and 3(2.11%)were sensitive to fosfomycin.Between 67-90 years old,17(12.87%)were sensitive to nitrofurantoin,and 4(3.03%)were tolerant to fosfomycin.Fosfomycin and nitrofurantoin showed good susceptibility in urinary isolates of E.coli and can be used empirically in our setup.

口服益生菌Escherichia coli Nissle 1917调控断奶仔猪空肠黏膜屏障功能的机理研究

旨在探讨口服益生菌Escherichia coli(E.coli)Nissle 1917调控病原菌E.coli Abbottstown攻毒或未攻毒21d断奶仔猪肠道屏障功能的机理。将20头21d断奶仔猪((6.35±0.38)kg)随机分为4组:(1)饲喂基础日粮的对照组(CON);(2)正试期口服E.coli Nissle 1917组(EcN);(3)预试期E.coli Abbottstown攻毒组(EcA);(4)预试期E.coli Abbottstown攻毒和正试期口服E.coli Nissle 1917组(EcN+EcA)。每个处理5个重复,每个重复1头仔猪。试验分为3d预试期和21d正试期。预试期EcA和EcN+EcA组的断奶仔猪接种5×10~9E.coli Abbottstown。正试期EcN和EcN+EcA组仔猪每天每头口服1×10~10E.coli Nissle 1917。试验结果表明,未攻毒的断奶仔猪中,与CON相比,口服1×10~10E.coli Nissle 1917能显著改善生长性能(P<0.05),降低腹泻率,提高oCcludin蛋白水平(P<0.05),显著降低空肠黏膜calprotectin蛋白水平(P<0.05),显著下调空肠黏膜蛋白激酶R(Protein kinase R,PKR)、toll样受体-2(Toll-like receptor-2,TLR-2)和真核起始因子-5A(eukaryotic initiation factor-5A,eIF-5A)mRNA的相对表达丰度(P<0.05),上调空肠黏膜内皮生长因子(Endothelial growth factor,EGF)、肝细胞生长因子(Hepatocyte growth factor,HGF)、胰岛素样生长因子(Insulin-like growth factor,IGF-I)、三叶肽因子-3(trefoil peptide factor-3,TFF-3)mRNA的相对表达丰度(P<0.05);在E.coli Abbottstown攻毒的断奶仔猪中,与EcA组相比,口服1×10~10E.coli Nissle 1917能显著改善生长性能(P<0.05),降低腹泻率,降低血清二胺氧化酶(DAO)活性(P<0.05)和一氧化氮(NO)含量(P<0.05),下调空肠黏膜PKR、eIF-5A和TLR-2 mRNA相对表达丰度(P<0.05),显著降低空肠黏膜calprotectin蛋白水平和淋巴细胞数量(P<0.05),显著提高空肠黏膜oCcludin蛋白水平(P<0.05),上调空肠黏膜IGF-I、HGF、TFF-3和EGF mRNA相对表达丰度(P<0.05)。本试验结果提示,口服1×10~10E.coli Nissle 1917能降低病原大肠杆菌攻毒或未攻毒21日龄断奶仔猪空肠黏膜屏障功能的损伤。

大肠杆菌Nissle 1917对炎症性肠病治疗作用的研究进展

炎症性肠病(inflammatory bowel disease,IBD)是一组特定的肠道疾病的统称,主要体现为慢性及复发性的肠道炎症。其全球发病率正在迅速上升,严重影响人们生活质量与生命健康,已成为当前的全球性健康问题。在过去的几十年里,大量研究表明IBD的发病率与肠道菌群失调有关。因此,以肠道益生菌为主的治疗策略成为一大热点,其中大肠杆菌Nissle 1917(Escherichia coli Nissle 1917,EcN)备受关注。本文聚焦肠道益生菌EcN在治疗IBD中的应用与机制,系统地综述了EcN的益生菌特性,概述EcN在临床实践中对IBD的治疗应用,同时从上皮屏障完整性调节、免疫调节、黏液屏障保护和肠道菌群稳态等方面阐述EcN治疗IBD的具体作用机制。此外,结合当前的研究现状,讨论了未来基于工程化EcN新疗法的发展前景,强调EcN在IBD治疗和预防中的适用性和可行性策略,并对该领域未来的研究方向进行了展望,为进一步深入研究EcN治疗IBD提供思路和参考。

Role and mechanisms of action of escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update

Ulcerative colitis (UC) is a chronic inflammatory disease, whose etiology is still unclear. Its pathogenesis involves an interaction between genetic factors, immune response and the “forgotten organ”, Gut Microbiota. Several studies have been conducted to assess the role of antibiotics and probiotics as additional or alternative therapies for Ulcerative Colitis. Escherichia coli Nissle (EcN) is a nonpathogenic Gram-negative strain isolated in 1917 by Alfred Nissle and it is the active component of microbial drug Mutaflor® (Ardeypharm GmbH, Herdecke, Germany and EcN, Cadigroup, In Italy) used in many gastrointestinal disorder including diarrhea, uncomplicated diverticular disease and UC. It is the only probiotic recommended in ECCO guidelines as effective alternative to mesalazine in maintenance of remission in UC patients. In this review we propose an update on the role of EcN 1917 in maintenance of remission in UC patients, including data about efficacy and safety. Further studies may be helpful for this subject to further the full use of potential of EcN.

Intestinal-borne dermatoses significantly improved by oral application of Escherichia coli Nissle 1917

AIM: To evaluate the effect of oral Escherichia coli (E. coli) Nissle application on the outcome of intestinal-borne dermatoses.METHODS: In a randomized, controlled, non-blinded prospective clinical trial 82 patients with intestinal-borne facial dermatoses characterized by an erythematous papular-pustular rash were screened. At the initiation visit 37 patients entered the experimental arm and 20 patients constituted the control arm. All 57 patients were treated with a vegetarian diet and conventional topical therapy of the dermatoses with ointments containing tetracycline, steroids and retinoids. In the experimental arm patients received a one month therapy with oral E. coli Nissle at a maintenance dose of 2 capsules daily. The experimental group was compared to a non-treatment group only receiving the diet and topical therapy. The primary outcome parameter was improvement of the dermatoses, secondary parameters included life quality and adverse events. In addition the immunological reaction profile (IgA, interleucin-8 and interferon-α) was determined. Furthermore the changes of stool consistency and the microbiota composition over the time of intervention were recorded.RESULTS: Eighty-nine percent of the patients with acne, papular-pustular rosacea and seborrhoic dermatitis responded to E. coli Nissle therapy with significant amelioration or complete recovery in contrast to 56% in the control arm (P < 0.01). Accordingly, in the E. coli Nissle treated patients life quality improved significantly (P < 0.01), and adverse events were not recorded. The clinical improvement was associated with a significant increase of IgA levels to normal values in serum as well as suppression of the proinflammatory cytokine IL-8 (P < 0.01 for both parameters). In the E. coli Nissle treated group a shift towards a protective microbiota with predominance of bifidobacteria and lactobacteria (> 107 CFU/g stool) was observed in 79% and 63% of the patients, respectively (P < 0.01), compared to no change in the control group without E. coli Nissle. Moreover, the detection rate of a pathogenic flora dropped from 73% to 14 % of the patients in the experimental arm (P < 0.01) with no significant change in the control arm (accounting 80% before and 70% after the observation period, P > 0.05). Accordingly, stool consistency, color and smell normalized in the E. coli Nissle treated patients.CONCLUSION: E. coli Nissle protects the mucus barrier by overgrowth of a favorable gut microbiota with less immunoreactive potential which finally leads to clinical improvement of intestinal borne dermatoses.

Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment

BACKGROUND Hepatic encephalopathy(HE)can be considered a result of dysregulated gutliver-brain axis function,where cognitive impairment can be reversed or prevented by the beneficial effects induced by"gut-centric"therapies,such as the administration of nonabsorbable disaccharides,nonabsorbable antibiotics,probiotics and prebiotics.AIM To assess the short-term efficacy and safety of the probiotic Escherichia coli Nissle(EcN)1917 strain compared to lactulose and rifaximin in patients with minimal/mild HE.METHODS From January 2017 to March 2020,a total of 45 patients with HE were enrolled in this prospective,single-centre,open-label,randomized study.Participants were randomly assigned at a ratio of 1:1:1 to one of the treatment groups:The EcN group(n=15),lactulose group(n=15)or rifaximin group(n=15)for a 1 mo intervention period.The main primary outcomes of the study were changes in serum ammonia and Stroop test score.The secondary outcomes were markers of a chronic systemic inflammatory response(ІL-6,ІL-8,and IFN-γ)and bacteriology of the stool flora evaluated by specialized nonculture techniques after a 1 mo intervention period.RESULTS Patients who were given rifaximin or EcN showed a more significant reduction in serum ammonia and normalization of Bifidobacteria and Lactobacilli abundance compared to the lactulose group.However,the most pronounced restoration of the symbiotic microflora was associated with EcN administration and characterized by the absence of E.coli with altered properties and pathogenic enterobacteria in patient faeces.In the primary outcome analysis,improvements in the Stroop test parameters in all intervention groups were observed.Moreover,EcN-treated patients performed 15%faster on the Stroop test than the lactulose group patients(P=0.017).Both EcN and rifaximin produced similar significant reductions in the proinflammatory cytokines INF-γ,IL-6 and IL-8.EcN was more efficient than lactulose in reducing proinflammatory cytokine levels.CONCLUSION The use of the probiotic EcN strain was safe and quite efficient for HE treatment.The probiotic reduced the ammonia content and the level of serum proinflammatory cytokines,normalized the gut microbiota composition and improved the cognitive function of patients with HE.The application of the EcN strain was more effective than lactulose treatment.

Evidence and Potential Antibacterial Mechanism of Chinese Traditional Medicine Compounds for the Development of E. coli

Astragalus membranaceus (huangqi), Allium sativum (garlic), Cinnamomum cassia (cinnamon), and Dolichos lablab L. (white hyacinth bean) are the traditional Chinese herbs that were used in prescriptions in treating diarrhea caused by bacterial infection. These herbs are relatively safe for use and investigation. This study aimed to investigate the effects of Astragalus membranaceus, Allium sativum, Cinnamomum cassia, and Dolichos lablab L. on the metabolism of Escherichia coli (E. coli). The growth rate of E. coli was monitored under the influence of each herb, revealing that Astragalus membranaceus and Allium sativum exhibited significant antibacterial activity, whereas Cinnamomum cassia and Dolichos lablab L. demonstrated moderate inhibitory effects on E. coli growth. Further inhibition zone testing allowed for the evaluation of each herb’s potency and the number of generations required for E. coli to develop resistance. Additionally, the impact of the four herbs on the expression of outer membrane protein A (OmpA) in E. coli was examined by using qPCR. The findings revealed that Astragalus membranaceus acted as a sustainable bactericide by inhibiting the growth and metabolism of E. coli MG1655 through the suppression of OmpA expression. These results suggest that Astragalus membranaceus has potential as a natural antimicrobial agent for treating E. coli infections.

Genotyping Characteristics of Human Fecal Escherichia coli and Their Association with Multidrug Resistance in Miyun District, Beijing

Objective To explore the genotyping characteristics of human fecal Escherichia coli(E. coli) and the relationships between antibiotic resistance genes(ARGs) and multidrug resistance(MDR) of E. coli in Miyun District, Beijing, an area with high incidence of infectious diarrheal cases but no related data.Methods Over a period of 3 years, 94 E. coli strains were isolated from fecal samples collected from Miyun District Hospital, a surveillance hospital of the National Pathogen Identification Network. The antibiotic susceptibility of the isolates was determined by the broth microdilution method. ARGs,multilocus sequence typing(MLST), and polymorphism trees were analyzed using whole-genome sequencing data(WGS).Results This study revealed that 68.09% of the isolates had MDR, prevalent and distributed in different clades, with a relatively high rate and low pathogenicity. There was no difference in MDR between the diarrheal(49/70) and healthy groups(15/24).Conclusion We developed a random forest(RF) prediction model of TEM.1 + baeR + mphA + mphB +QnrS1 + AAC.3-IId to identify MDR status, highlighting its potential for early resistance identification. The causes of MDR are likely mobile units transmitting the ARGs. In the future, we will continue to strengthen the monitoring of ARGs and MDR, and increase the number of strains to further verify the accuracy of the MDR markers.

Escherichia coli Pathotypes in Children with Acute Diarrhea in an Informal Settlement in Nairobi, Kenya

Diarrhea is among the leading causes of morbidity and mortality in children aged Escherichia coli (DEC) accounts for 30% - 40% of childhood diarrhea cases. To identify the pathotypes involved in diarrheal outbreaks in Kenya, we analyzed archived E. coli isolates from children E. coli confirmation and antimicrobial susceptibility testing were done using the VITEK®2 instrument. Pathotype identification was performed via conventional polymerase chain reaction. Of 175 E. coli isolates, 48 (27%) were DEC pathotypes, with enteroaggregative E. coli (EAEC) predominating (71%, 34/48). Enterohemorrhagic (EHEC) and enteropathogenic E. coli (EPEC) represented 19% and 10% of isolates, respectively. Enteroinvasive and enterotoxigenic pathotypes were not identified. All DEC isolates were susceptible to amikacin, ertapenem, imipenem, meropenem and tigecycline. Conversely, most (>80%) isolates were resistant to ampicillin, ampicillin-sulbactam and sulfamethoxazole-trimethoprim. Half of all EAEC and EPEC strains were resistant to cefazolin while half of EHEC isolates were resistant to ciprofloxacin and moxifloxacin. In total, 18 resistance phenotypes were identified with “ampicillin-cefazolin-ampicillin/ sulbactam-sulfamethoxazole/trimethoprim” predominating (33%, 16/48). The majority (81%) of DEC isolates were multidrug-resistant, with extended-spectrum beta-lactamase production identified in 8% of these isolates. This study highlights the predominance of Enteroaggregative E. coli and multidrug resistance of DEC pathotypes. Studying the epidemiology of diarrheal disease and antimicrobial resistance surveillance, will aid in identifying dominant etiological agents of diarrhea and newly emerging resistant strains in informal settlements.

2种氟喹诺酮类抗生素与群体感应抑制剂对E.coli的联合毒性效应

抗生素滥用带来严重的细菌耐药性,威胁生态环境和人体健康。群体感应抑制剂(quorum sensing inhibitors,QSIs)作为一种理论上难以引发细菌耐药性的新型潜在抗生素替代品,被建议单独使用或与传统抗生素联合使用。因此,考察抗生素与QSIs联合作用效应及其作用机理对其在环境中可能产生的联合暴露风险评估具有重要的参考意义。以应用较广泛的2种氟喹诺酮类药物氧氟沙星(ofloxacin,OFL)、左氧氟沙星(levofloxacin,LEV)和1种新型抗菌剂群体感应抑制剂4-羟基-2,5-二甲基-3(2H)呋喃酮(4-hydroxy-2,5-dimethyl-3(2H)-furanone,HDMF)为研究对象,运用直接均分法和均匀设计射线法分别设计3个二元和1个三元混合物体系,每个体系包含5条具有不同组分浓度比的射线。应用时间毒性微板分析法测定3种药物及其混合物体系对大肠杆菌(Escherichia coli,E.coli)的毒性,应用拟合归零法分析混合物的毒性相互作用及相互作用强度,采用分子间对接技术来探讨可能存在的作用机理。结果表明,HDMF、OFL、LEV对E.coli均具有浓度、时间依赖毒性,以半数效应浓度负对数为毒性指标,3种药物在同一暴露时间毒性顺序:LEV>OFL>HDMF。3种药物的二元混合物体系相互作用类型有拮抗/协同作用,而三元混合物体系的作用类型为协同作用,且作用类型和强度受混合物组分、暴露时间和浓度影响。氟喹诺酮类药物混合物体系中,因药物竞争结合蛋白点位而呈现出拮抗作用。在氟喹诺酮类药物和QSIs混合体系中,QSIs会破坏细菌的生物膜,使氟喹诺酮类药物更容易接触细菌造成损伤,从而呈现协同作用。但随着暴露时间的延长,氟喹诺酮类药物会对DNA造成损伤进而减少QSIs作用蛋白的产生,呈现出拮抗作用。

Detection of aac(3)IIc, aac(6)Ib, armA Genes Coding for Escherichia coli Resistance to Aminoglycosides in Burkina Faso

Background and Prupose: Antibiotic resistance is a major global health concern. In addition to the existing data on the prevalence of bacterial resistance to antibiotics, there are patchy data on bacterial resistance to aminoglycosides in Burkina Faso. In this study, we determined the prevalence of aminoglycoside resistance genes in E. coli, including aac(3)-IIc, aac(6)-Ib and armA in Ouagadougou, and determined which antibiotics in this class are most affected by resistance. Material and Methods: This study was conducted on 216 E. coli strains collected from the biomedical analysis laboratories of Saint Camille and Schiphra hospitals. E. coli strains were isolated from pus and urine samples collected between September 2018 and January 2019. Antibiotic susceptibility testing was performed using aminoglycosides, β-lactams, fluoroquinolones, and sulfonamides. Aminoglycoside resistance genes were detected in strains with at least one aminoglycoside resistance gene using conventional/multiplex PCR. Results: Aminoglycoside resistance was observed in 46.8% (101/216) of strains. The resistance rates were respectively 45.37% for Tobramycin, 32.40% for Gentamicin, 14.81% for Kanamycin, 2.31% for Netilmicin, 1.84% for Neomycin, and 0.46% for Amikacin. PCR showed that 86 strains (85.15%) possessed the aac(3)-IIc gene, 71 strains or 70.30%) possessed the aac(6’)-Ib gene, and nine strains (8.91%) possessed the armA gene. Conclusion: Aminoglycoside resistance in pathogenic E. coli strains is mainly due to the presence of the aac(3’)-IIc and aac(6’)-Ib genes. The presence of armA was first reported in Burkina Faso. Netilmicin, Neomycin and Amikacin are good therapeutic options for treating urinary tract and pus-forming infections.

E.coli Nissle 1917(EcN)curli菌毛和鞭毛对其生物被膜形成的影响

E.coli Nissle 1917是被广泛认可的益生菌,可以通过形成生物被膜定殖在肠道中抑制沙门氏菌等病原菌的生长。通过λ-Red同源重组系统构建curli菌毛合成基因(csgA)和鞭毛调控基因(hnsA)突变菌株,探究curli菌毛和鞭毛对EcN生物被膜形成的影响。结果表明,curli菌毛对EcN运动能力以及生物膜形成没有影响;EcNΔhnsA菌株的运动能力下降,生物被膜含量升高,说明鞭毛通过促进EcN运动,抑制细菌的附着,从而抑制生物膜的形成。

De Novo Synthesis of Biopaint Using Transformed Bacteria: Analysis of Spectral Intensity Trends and Comparison to Commercial Paint

Background: Commercial paint pigments contain toxic heavy metals that harm humans and pollute the environment. To mitigate these harms, ecologically safe pigments are necessary. Objective: This experiment aims to create a biopaint de-novo using transformed Escherichia coli bacteria and compare it to commercial paint. Methods: Genetically engineered E. coli bacteria producing magenta pigment were grown in petri dishes. The pigment protein was extracted, filtered, and dehydrated into a crystalline powder. This was mixed with acrylic medium to make biopaint. The biopaint and commercial paint were applied on acrylic paper;red, green, blue, and total spectral intensities were measured daily under different testing conditions. Spectral intensity variability was measured and compared using the Coefficient of Variation (CV). Trends in spectral intensity were analyzed using regression analysis. Results: The differences in the CV of biopaint to commercial paint were less than 20% under all testing conditions. Spectral intensities for both biopaint and commercial paint did not show any significant change during the testing period under the conditions of room temperature, heat, and humidity. However, under the cold testing condition, biopaint showed a slight but statistically significant (p-value Conclusion: This experiment proves that E. coli-derived pigments can be used to make biopaint which has a similar durability to commercial paint as measured by the spectral intensities.